Bagalanon, Elenita V.
HRN: 16-44-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2023
CEFTAZIDIME 1GM (VIAL)
11/07/2023
11/14/2023
IV
2g
Q8
Abscess And Folliculitis On DM
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes